Avista Capital Partners logo

Avista Capital Partners

North America, New York, United States, New York

Description

Avista Capital Partners is a private equity firm that primarily invests in healthcare companies.

Investor Profile

Avista Capital Partners has made 6 investments, with 0 in the past 12 months and 17% as lead.

Stage Focus

  • Private Equity (33%)
  • Series C (33%)
  • Debt Financing (17%)
  • Series D (17%)

Country Focus

  • Norway (67%)
  • United States (33%)

Industry Focus

  • Medical Device
  • Pharmaceutical
  • Biotechnology
  • Health Care
  • Energy
  • Natural Resources
  • Oil And Gas
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Avista Capital Partners frequently co-invest with?

WFD Ventures
North America, New York, United States, New York
Co-Investments: 3
New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 1
Entrepreneurs Fund
Europe, England, United Kingdom, London
Co-Investments: 2
The Entrepreneurs' Fund
North America, California, United States, San Mateo
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 1
Deerfield Capital Management
North America, Illinois, United States, Rosamond
Co-Investments: 1
Apple Tree Partners
North America, New York, United States, New York
Co-Investments: 1
WC
North America, Maryland, United States, Bethesda
Co-Investments: 1
Old Ironsides Energy
North America, Massachusetts, United States, Boston
Co-Investments: 1

What are some of recent deals done by Avista Capital Partners?

Braeburn

Plymouth Meeting, Pennsylvania, United States

We transform the management of OUD to help people begin and sustain recovery.

Health CareMedical DevicePharmaceutical
Debt FinancingJan 10, 2018
Amount Raised: $110,000,000
OptiNose

Oslo, Oslo, Norway

OptiNose develops nasal drug delivery technologies and combined drug and device therapies.

BiotechnologyMedical DevicePharmaceutical
Series DMay 9, 2017
Amount Raised: $37,000,000
OptiNose

Oslo, Oslo, Norway

OptiNose develops nasal drug delivery technologies and combined drug and device therapies.

BiotechnologyMedical DevicePharmaceutical
Series COct 6, 2015
Amount Raised: $30,000,000
OptiNose

Oslo, Oslo, Norway

OptiNose develops nasal drug delivery technologies and combined drug and device therapies.

BiotechnologyMedical DevicePharmaceutical
Series CAug 5, 2014
Amount Raised: $35,000,000
Laredo Energy

Houston, Texas, United States

Laredo Energy is a privately held company.

EnergyNatural ResourcesOil and Gas
Private EquityMay 29, 2014
Amount Raised: $130,000,000
OptiNose

Oslo, Oslo, Norway

OptiNose develops nasal drug delivery technologies and combined drug and device therapies.

BiotechnologyMedical DevicePharmaceutical
Private EquityJun 7, 2010
Amount Raised: $48,500,000